GGrantIndex
← Leaderboards

Scott M Landfear

Oregon Health And Science University

Google Scholar ↗PubMed ↗ORCID ↗
$24,659,987
Attributed
$26,365,188
Total exposure
16
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,365,188 · 16

By mechanism

R01$11,631,362 · 4
T32$6,882,717 · 2
R21$2,557,523 · 6
U01$2,026,198 · 1
U54$1,878,277 · 1
R33$1,360,442 · 1

Top collaborators

Others in their field

Top investigators on “Parasites”

Research focus

ParasitesMutantLaboratoriesGlucose TransporterGenesPharmaceutical PreparationsLeishmaniaIn VitroMacrophageBaseMediatingMonitorMolecularCellsLife Cycle StagesPropertyProtozoaProteinsLeishmania DonovaniPlayEnvironmentPermeaseLeishmania (Genus)Leishmania Mexicana

Grant awards (76)

Function and Trafficking of Flagellar Membrane Proteins in Leishmania mexicana$673,091
U01 · FY2025 · AI · contact PI
Interdisciplinary Training in Microbial Pathogenesis and Immunology$394,648
T32 · FY2025 · AI · contact PI
Function and Trafficking of Flagellar Membrane Proteins in Leishmania mexicana$673,091
U01 · FY2024 · AI · contact PI
Interdisciplinary Training in Microbial Pathogenesis and Immunology$396,721
T32 · FY2024 · AI · contact PI
Function and Trafficking of Flagellar Membrane Proteins in Leishmania mexicana$680,016
U01 · FY2023 · AI · contact PI
Interdisciplinary Training in Microbial Pathogenesis and Immunology$372,518
T32 · FY2023 · AI
The Neddylation Pathway in Leishmania donovani - A High Opportunity Target$192,500
R21 · FY2022 · AI · contact PI
Development of Novel Natural Product Inspired Antileishmanial Drugs$189,593
R21 · FY2022 · AI · contact PI
Development of Novel Therapeutics for Leishmaniasis$446,184
R33 · FY2021 · AI · contact PI
Development of Novel Natural Product Inspired Antileishmanial Drugs$241,593
R21 · FY2021 · AI · contact PI
The Neddylation Pathway in Leishmania donovani - A High Opportunity Target$231,000
R21 · FY2021 · AI · contact PI
Function of the Essential KHARON1 Protein in Bloodstream Form African Trypanosomes$524,134
R01 · FY2020 · AI · contact PI
Development of Novel Therapeutics for Leishmaniasis$454,661
R33 · FY2020 · AI · contact PI
Function of the Essential KHARON1 Protein in Bloodstream Form African Trypanosomes$524,134
R01 · FY2019 · AI · contact PI
Development of Novel Therapeutics for Leishmaniasis$459,597
R33 · FY2019 · AI · contact PI
Interactions at the Microbe/Host Interface$431,534
T32 · FY2019 · AI · contact PI
Function of the Essential KHARON1 Protein in Bloodstream Form African Trypanosomes$524,134
R01 · FY2018 · AI · contact PI
Interactions at the Microbe/Host Interface$407,721
T32 · FY2018 · AI · contact PI
Development of Novel Therapeutics for Leishmaniasis$189,589
R21 · FY2018 · AI · contact PI
Function of the Essential KHARON1 Protein in Bloodstream Form African Trypanosomes$524,134
R01 · FY2017 · AI · contact PI
Interactions at the Microbe/Host Interface$378,183
T32 · FY2017 · AI · contact PI
Development of Novel Therapeutics for Leishmaniasis$242,748
R21 · FY2017 · AI · contact PI
Interactions at the Microbe/Host Interface$5,424
T32 · FY2017 · AI · contact PI
Function of the Essential KHARON1 Protein in Bloodstream Form African Trypanosomes$524,134
R01 · FY2016 · AI · contact PI
Interactions at the Microbe/Host Interface$417,403
T32 · FY2016 · AI · contact PI
The Role of the Kharon Complex in Leishmania Virulence$192,500
R21 · FY2016 · AI · contact PI
Development of Drugs that Target the Malaria Hexose Transporter$192,500
R21 · FY2016 · AI · contact PI
Interactions at the Microbe/Host Interface$408,746
T32 · FY2015 · AI · contact PI
Development of Drugs that Target the Malaria Hexose Transporter$231,000
R21 · FY2015 · AI · contact PI
The Role of the Kharon Complex in Leishmania Virulence$231,000
R21 · FY2015 · AI · contact PI
Interactions at the Microbe/Host Interface$395,377
T32 · FY2014 · AI · contact PI
Purine Nucleoside/Nucleobase Transporters in Leishmania$381,150
R01 · FY2014 · AI · contact PI
Selective Inhibitors of the Hexose Transporter from African Trypansomes$192,500
R21 · FY2014 · AI · contact PI
Interactions at the Microbe/Host Interface$390,504
T32 · FY2013 · AI · contact PI
Purine Nucleoside/Nucleobase Transporters in Leishmania$358,281
R01 · FY2013 · AI · contact PI
Selective Inhibitors of the Hexose Transporter from African Trypansomes$231,000
R21 · FY2013 · AI · contact PI
Career Development and Training Plan$147,644
U54 · FY2013 · AI · contact PI
Interactions at the Microbe/Host Interface$390,504
T32 · FY2012 · AI · contact PI
Purine Nucleoside/Nucleobase Transporters in Leishmania$381,150
R01 · FY2012 · AI · contact PI
Career Development and Training Plan$187,067
U54 · FY2012 · AI · contact PI
Career Development and Training Plan$523,958
U54 · FY2011 · AI · contact PI
Interactions at the Microbe/Host Interface$385,476
T32 · FY2011 · AI · contact PI
Purine Nucleoside/Nucleobase Transporters in Leishmania$381,150
R01 · FY2011 · AI · contact PI
IDENTIFICATION OF PTMS ON RIBOKINASE FROM LEISHMANIA MEXICANA$28,669
P41 · FY2011 · RR · contact PI
Career Development and Training Plan$506,333
U54 · FY2010 · AI · contact PI
Purine Nucleoside/Nucleobase Transporters in Leishmania$385,000
R01 · FY2010 · AI · contact PI
Interactions at the Microbe/Host Interface$380,577
T32 · FY2010 · AI · contact PI
Functional Characterization of Leishmania Transporters$363,066
R01 · FY2010 · AI · contact PI
Development of Assay for High Throughput Screen of Parasite Glucose Transporter$228,690
R01 · FY2010 · AI · contact PI
Career Development and Training Plan$513,275
U54 · FY2009 · AI · contact PI
Functional Characterization of Leishmania Transporters$366,733
R01 · FY2009 · AI · contact PI
Interactions at the Microbe/Host Interface$348,021
T32 · FY2009 · AI · contact PI
Development of Assay for High Throughput Screen of Parasite Glucose Transporter$231,000
R01 · FY2009 · AI · contact PI
Functional Characterization of Leishmania Transporters$366,733
R01 · FY2008 · AI · contact PI
Interactions at the Microbe/Host Interface$345,650
T32 · FY2008 · AI · contact PI
Nucleoside/Nucleobase Transporters in Leishmania major$316,025
R01 · FY2008 · AI · contact PI
Development of Assay for High Throughput Screen of Parasite Glucose Transporter$193,740
R01 · FY2008 · AI · contact PI
Functional Characterization of Leishmania Transporters$373,734
R01 · FY2007 · AI · contact PI
Interactions at the Microbe/Host Interface$345,650
T32 · FY2007 · AI · contact PI
Nucleoside/Nucleobase Transporters in Leishmania major$322,145
R01 · FY2007 · AI · contact PI
Functional Characterization of Leishmania Transporters$383,541
R01 · FY2006 · AI · contact PI
Interactions at the Microbe/Host Interface$345,650
T32 · FY2006 · AI · contact PI
Nucleoside/Nucleobase Transporters in Leishmania major$331,767
R01 · FY2006 · AI · contact PI
Interactions at the Microbe/Host Interface$342,410
T32 · FY2005 · AI
Nucleoside/Nucleobase Transporters in Leishmania major$339,750
R01 · FY2005 · AI
Functional Characterization of Leishmania Transporters$339,750
R01 · FY2005 · AI
Nucleoside/Nucleobase Transporters in Leishmania major$339,750
R01 · FY2004 · AI
Functional Characterization of Leishmania Transporters$339,750
R01 · FY2004 · AI
Functional Characterization of Leishmania Transporters$339,750
R01 · FY2003 · AI
NUCLEOSIDE TRANSPORTERS IN LEISHMANIA AND TRYPANOSOMES$265,365
R01 · FY2003 · AI
Functional Characterization of Leishmania Transporters$339,750
R01 · FY2002 · AI
NUCLEOSIDE TRANSPORTERS IN LEISHMANIA AND TRYPANOSOMES$257,637
R01 · FY2002 · AI
Functional Characterization of Leishmania Transporters$305,775
R01 · FY2001 · AI
NUCLEOSIDE TRANSPORTERS IN LEISHMANIA AND TRYPANOSOMES$250,131
R01 · FY2001 · AI
FUNCTIONAL CHARACTERIZATION OF LEISHMANIA TRANSPORTER$286,534
R01 · FY2000 · AI
NUCLEOSIDE TRANSPORTERS IN LEISHMANIA AND TRYPANOSOMES$242,845
R01 · FY2000 · AI